Search Results 401-410 of 1004 for ���������������������������������������������:PC90���
At the first U.S. 'Undiagnosed Hackathon,' scientists from around the world will team up at Mayo Clinic to solve unsolved medical mysteries. Young Julian Limon[ ...
JACKSONVILLE, Fla. — Mayo Clinic's pioneering exploration of stem cell-based therapies for bone loss is headed to space. Abba Zubair, M.D., Ph.D., ...
The purpose of this study is to evaluate the effectiveness of PCS499 at 6 Months in treating ulcerations in patients who have necrobiosis lipoidica.
ROCHESTER, Minn. — A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 ...
The primary purpose of this study is to evaluate whether early treatment with therapeutic hypothermia (TH), along with neuromuscular blockade (NMB) to prevent ...
Doxorubicin is a medicine already used to treat cancer including liposarcoma. During the study, participants get either BI 907828 or doxorubicin. Every 3 weeks, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study will evaluate the effectiveness of cryoablation for palliation of painful metastases in patients with metastatic lesions involving bone who have ...
The purpose of this study is to develop two quantitative risk scores for MAC-PD that computationally integrates clinical, immunological, and pharmacological ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.